These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11078908)

  • 1. Expression of a truncated epidermal growth factor receptor in oral squamous cell carcinomas.
    Kiyota A; Shintani S; Mihara M; Nakahara Y; Ueyama Y; Matsumura T; Todd R; Wong DT
    Cancer Lett; 2000 Dec; 161(1):9-15. PubMed ID: 11078908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas.
    Hiraishi Y; Wada T; Nakatani K; Negoro K; Fujita S
    Pathol Oncol Res; 2006; 12(2):87-91. PubMed ID: 16799709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
    Mehta A; Chowdhary M; Sinha R
    J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas.
    Bánkfalvi A; Krassort M; Végh A; Felszeghy E; Piffkó J
    J Oral Pathol Med; 2002 Sep; 31(8):450-7. PubMed ID: 12220351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
    Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
    BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR and PCNA expression in oral squamous cell carcinomas--a valuable tool in estimating the patient's prognosis.
    Störkel S; Reichert T; Reiffen KA; Wagner W
    Eur J Cancer B Oral Oncol; 1993 Oct; 29B(4):273-7. PubMed ID: 11706420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
    Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
    Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations.
    Aquino G; Pannone G; Santoro A; Liguori G; Franco R; Serpico R; Florio G; De Rosa A; Mattoni M; Cozza V; Botti G; Losito S; Longo F; Staibano S; Cuda G; Lo Muzio L; Sbordone C; Bufo P; Grimaldi A; Caraglia M; Di Domenico M
    Cancer Biol Ther; 2012 Sep; 13(11):967-77. PubMed ID: 22825335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
    Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
    Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR amplification and expression in oral squamous cell carcinoma in young adults.
    Costa V; Kowalski LP; Coutinho-Camillo CM; Begnami MD; Calsavara VF; Neves JI; Kaminagakura E
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):817-823. PubMed ID: 29395668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.
    Silva SD; Alaoui-Jamali MA; Hier M; Soares FA; Graner E; Kowalski LP
    Clin Exp Metastasis; 2014 Mar; 31(3):307-16. PubMed ID: 24338375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of histone H3 serine 10 phosphorylation and histone H4 lysine 12 acetylation in oral squamous cell carcinoma.
    Campos-Fernández E; Matsuo FS; Andrade MF; Servato JPS; Loyola AM; Cardoso SV; Siva SJ; Moraes ADS; de Faria PR
    Histopathology; 2019 Jan; 74(2):227-238. PubMed ID: 30007038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.
    Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
    Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR expression and copy number changes in low T-stage oral squamous cell carcinomas.
    Rössle M; Weber CS; Züllig L; Graf N; Jochum W; Stöckli SJ; Moch H; Huber GF
    Histopathology; 2013 Aug; 63(2):271-8. PubMed ID: 23763474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis.
    Bates T; Kennedy M; Diajil A; Goodson M; Thomson P; Doran E; Farrimond H; Thavaraj S; Sloan P; Kist R; Robinson M
    Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):927-35. PubMed ID: 27197272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
    Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
    Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.